Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results
Boston Scientific (NYSE: BSX) will participate in the 44th Annual J.P.
Rhea-AI Summary
Boston Scientific (NYSE: BSX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 with a 40-minute Q&A starting at approximately 9:00 a.m. PT / 12:00 p.m. ET. Presenters include Mike Mahoney (chairman & CEO), Jon Monson (EVP & CFO) and Ken Stein, M.D. (SVP & global chief medical officer).
The company will also host a webcast conference call to discuss fourth quarter and full year results for the period ended December 31, 2025 on February 4, 2026 at 8:00 a.m. ET, preceded by a news release. Live webcasts and replays will be available at https://investors.bostonscientific.com, with replays posted about one hour after each event.
Positive
- None.
Negative
- None.
Details
News Market Reaction – BSX
In the Jan 2 session, BSX declined 0.67%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference
- Q&A session length
- 40 minutes
- J.P. Morgan Healthcare Conference Q&A session
- Session start time
- 9:00 a.m. PT / 12:00 p.m. ET
- J.P. Morgan Healthcare Conference Q&A
- Conference date
- January 13, 2026
- J.P. Morgan Healthcare Conference participation
- Earnings call date
- February 4, 2026
- Q4 and full-year 2025 results conference call
- Earnings call time
- 8:00 a.m. ET
- Q4 and full-year 2025 results conference call
- Reporting period
- Fourth quarter and full year 2025
- Financial results to be discussed on February 4, 2026
- Replay availability
- Approximately one hour post-event
- Webcast replay for both events
Historical Context
-
New chairman at CathVision and ECGenius System Version 3.5 commercial release.
-
Participation in Wolfe and Citi healthcare investor conferences announced.
-
Strong Q3 sales and EPS above guidance with raised 2025 outlook.
-
Agreement to acquire Nalu Medical to expand neuromodulation portfolio.
-
Announcement of 2025 Investor Day and Q3 2025 earnings call timing.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Jargon Translator
AI-generated analysis. How Rhea-AI works. Not financial advice.
Additionally, the company will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year ended December 31, 2025, on Wednesday, February 4, 2026, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney and Jon Monson. The company will issue a news release announcing financial results for the fourth quarter and full year 2025 on February 4 prior to the conference call.
A live webcast and replay for each event will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn.
CONTACTS:
Emily Anderson
Media Relations
+1 (617) 515-2000
Emily.Anderson2@bsci.com
Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-participation-in-the-jp-morgan-healthcare-conference-and-conference-call-discussing-fourth-quarter-and-full-year-2025-results-302648097.html
SOURCE Boston Scientific Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.